scholarly article | Q13442814 |
P50 | author | David Mabey | Q37834883 |
Michael Marks | Q42786147 | ||
Chrissy H Roberts | Q56426648 | ||
Robert Butcher | Q56781523 | ||
Naomi Cocks | Q64364636 | ||
Mike Kama | Q78549817 | ||
Stephanie J Migchelsen | Q83428337 | ||
Colin K. Macleod | Q88123720 | ||
Chelsea Yalen | Q117278869 | ||
P2093 | author name string | Apisalome Nakolinivalu | |
Merelesita Rainima-Qaniuci | |||
P2860 | cites work | Trachoma and Yaws: Common Ground? | Q26775120 |
CT694 and pgp3 as serological tools for monitoring trachoma programs | Q28484816 | ||
Serology for trachoma surveillance after cessation of mass drug administration | Q28543658 | ||
Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji | Q28596379 | ||
Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based system | Q28660227 | ||
Endemic treponemal diseases | Q34172900 | ||
A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles | Q34364970 | ||
Global epidemiology of yaws: a systematic review | Q34669935 | ||
A cluster randomized study of the safety of integrated treatment of trachoma and lymphatic filariasis in children and adults in Sikasso, Mali | Q34723495 | ||
Scabies and impetigo prevalence and risk factors in Fiji: a national survey | Q35148030 | ||
Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws | Q35737445 | ||
Serological Measures of Trachoma Transmission Intensity | Q36387948 | ||
The development and validation of dried blood spots for external quality assurance of syphilis serology | Q36650928 | ||
The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation | Q37063682 | ||
Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project | Q37835251 | ||
Prevalence of Chlamydia trachomatis infection in Samoan women aged 18 to 29 and assessment of possible risk factors: a community-based study. | Q37841692 | ||
Chlamydia in the Pacific region, the silent epidemic | Q37857163 | ||
The prevalence of sexually transmitted disease agents in pregnant women in Suva | Q37901362 | ||
Development of a new platform for neglected tropical disease surveillance | Q39158723 | ||
Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands | Q42388331 | ||
Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology | Q68453367 | ||
Eradication of yaws--the Morges strategy | Q95491021 | ||
P433 | issue | 10 | |
P921 | main subject | yaws | Q76973 |
seroprevalence | Q3511357 | ||
Fiji | Q5425748 | ||
P304 | page(s) | 582-587 | |
P577 | publication date | 2016-11-16 | |
P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
P1476 | title | Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji | |
P478 | volume | 110 |
Q62898910 | A search for trachoma in Timor-Leste: no evidence to justify undertaking population-based prevalence surveys |
Q59804310 | A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands |
Q62898898 | Absence of Serological Evidence of Exposure to Treponema pallidum among Children Suggests Yaws Is No Longer Endemic in Kiribati |
Q56365896 | Advancing the public health applications of Chlamydia trachomatis serology |
Q54943022 | Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis. |
Q52642699 | Community-based mass treatment with azithromycin for the elimination of yaws in Ghana-Results of a pilot study. |
Q43924390 | Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3. |
Q56355704 | Comparison of three serological assays to measure antibody response to Chlamydia antigen Pgp3 in adolescent and young adults with pelvic inflammatory disease |
Q89527701 | Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma |
Q40045638 | Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati |
Q43366299 | Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia |
Q60300335 | The utility of serology for elimination surveillance of trachoma |
Search more.